STAT

MARCH 24, 2025

Five years ago, the Covid-19 pandemic swept through the world, resulting in massive disruptions, including to biomedical researchers. As National Institutes of Health-funded physician-scientists, we collectively experienced the pitfalls of lab closures, pauses in clinical trial recruitment due to staffing issues and social distancing policies affecting in-person accrual, and redeployment away from research work to the frontlines to support clinical care.

286

286

PharmaVoice

MARCH 24, 2025

The FDA delisted semaglutide and tirzepatide from its shortage list, putting an end to copycat GLP-1s.

Compounding 130

Compounding 130

STAT

MARCH 24, 2025

23andMe said late Sunday it will file for bankruptcy and CEO and co-founder Anne Wojcicki will depart, after she repeatedly tried and failed to take the storied but financially troubled DNA-testing startup private.  The company will now try to sell itself through a court-supervised sale. It closed Friday valued at a hair under $50 million, a calamitous fall from 2021, when it went public and soared to a nearly $6 billion market cap.

259

259

PharmaVoice

MARCH 24, 2025

The companies are striving to bring fresh innovations to cancer care, pain management and the weight loss space.

130

130

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

MARCH 24, 2025

WASHINGTON — Five days after discovering their 16-year-old son Daniel Puerta unresponsive in bed, Jaime Puerta and his wife decided to discontinue life support as they stood beside him in the Los Angeles Children’s Hospital. Puerta kissed his son’s nose one last time. Daniel, who had no history of drug use, is one of countless stories tragically connected to the nation’s opioid crisis.

Hospitals 227

Hospitals 227

STAT

MARCH 24, 2025

Small, early-stage biotech startups are the heart of drug innovation in the U.S. Growing anti-competitive challenges threaten their work, but philanthropy may offer an avenue forward. At the center of these challenges is the U.S. patent system and how it incentivizes anti-competitive behavior among the most powerful players. The argument is that patents — meant to spur innovation — are being gamed by drug manufacturers to extend monopoly profits and exclusivity, stifling competitio

205

205

BioPharma Dive

MARCH 24, 2025

Speed vs. success in oncology trials: Discover data-driven strategies to accelerate drug development.

Drug Development 98

Drug Development 98

STAT

MARCH 24, 2025

Morning. Today, we’re taking a look at the profound impact of funding cuts on cancer research under the Trump administration. Also, venture investors are pivoting away from gene therapies and leaning into faster-return areas like obesity and cancer.  Can philanthropy rescue struggling small biotechs? Small biotech startups drive most drug innovation in the U.S., but they’re getting squeezed by the drug industry’s anti-competitive tactics and a patent system that rewards

Drug Pricing 157

Drug Pricing Drug Development 157

Pharmaceutical Technology

MARCH 24, 2025

AstraZeneca has announced a $2.5bn investment to establish the companys sixth worldwide strategic R&D centre in China.

87

87

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

MARCH 24, 2025

This is the online version of STAT’s email newsletter Health Care Inc., delivered to your inbox every Monday.  Sign up here.  Well hello, everyone! I’m out this week, which means my buddy Tara Bannow is going to be taking the helm of this newsletter next Monday. You know what to do: Send her all of your tips, gossip, and random musings at tara.bannow@statnews.com.

137

137

pharmaphorum

MARCH 24, 2025

Novo Nordisk has moved to shore up its obesity pipeline with a $2bn licensing deal for a triple agonist developed by China's United Biotechnology

85

85

STAT

MARCH 24, 2025

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of meetings, deadlines, and messages has returned. But what can you do? There is no pause button to stop the world from spinning. To cope, we are quaffing cups of stimulation. Our choice today is peppermint.

137

137

Pharma Times

MARCH 24, 2025

Pfizers Abrysvo is designed to prevent RSV-associated disease in infants

Vaccines 75

Vaccines 75

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

MARCH 24, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! I’ve got a meaty issue for you here to start the week. Thanks so much for reading.

Hospitals 130

Hospitals 130

Express Pharma

MARCH 24, 2025

STEER World, a global leader in advanced materials processing technology, has announced a collaboration with Gericke, a Switzerland-based expert in powder processing equipment and system integration. This partnership aims to deliver a truly continuous granulation system tailored to the needs of pharmaceutical manufacturers, transforming the production of Oral Solid Dosage (OSD) forms.

Pharmaceutical Manufacturing 66

Pharmaceutical Manufacturing Dosage 66

BioPharma Dive

MARCH 24, 2025

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.

62

62

pharmaphorum

MARCH 24, 2025

Explore the importance of incorporating AI and ethics in pharmaceutical investment for the future. Learn about the impact and benefits of these technologies in the industry.

59

59

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharmaceutical Technology

MARCH 24, 2025

Augustine Therapeutics has raised 78m ($85m) in funding to support the development of its lead candidate as it enters a Phase I/II trial in Charcot-Marie-Tooth (CMT) disease.

59

59

pharmaphorum

MARCH 24, 2025

After its lead wet AMD drug failed a phase 3 trial, Opthea may have to make massive repayments to investors that would threaten its viability

59

59

Pharmaceutical Technology

MARCH 24, 2025

The government of Alberta has announced a collaboration with Siemens Healthineers and the Alberta Cancer Foundation, investing C$800m.

59

59

pharmaphorum

MARCH 24, 2025

Belgian startup Augustine raises 78m ($85m) in first-round funding for HDAC6 inhibitors headed by a candidate for Charcot-Marie-Tooth disease.

59

59

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Technology

MARCH 24, 2025

The FDA has granted approval for the IND application of Everest Medicines tumour-associated antigen (TAA) vaccine, EVM14.

Vaccines 59

Vaccines 59

BioPharma Dive

MARCH 24, 2025

The Series B round will help the Aditum Bio-backed startup fund two mid-stage clinical trials in people with alcohol and cocaine use disorders.

57

57

Pharmaceutical Commerce

MARCH 24, 2025

Peter Wells, CEO of TemperPack, discusses the life sciences industry's shift toward sustainable packaging, particularly in cold chain logistics, to replace outdated petroleum-based materials like expanded polystyrene (EPS). His insights cover the growing importance of sustainability as a business driver, emphasizing efficiency, waste reduction, regulatory pressures, and emerging innovations in biodegradable and recyclable packaging solutions.

52

52

PharmExec

MARCH 24, 2025

The facility, which is set to open amid Biogens 50th anniversary, will integrate research and development, technical operations, and commercial teams into one location.

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.